Literature DB >> 25146713

Does screening for Down's syndrome cause anxiety in pregnant women? A systematic review.

Stina Lou1, Line Mikkelsen, Lone Hvidman, Olav B Petersen, Camilla Palmhøj Nielsen.   

Abstract

BACKGROUND: Prenatal screening for Down's syndrome and other chromosomal abnormalities is included in prenatal care programs in many countries. However, the potential association between prenatal screening and maternal anxiety remains an issue of debate.
OBJECTIVE: To systematically review and summarize the current scientific evidence on whether screening for Down's syndrome might cause anxiety in pregnant women with a negative or a false-positive screening result.
METHODS: Five databases (PubMed, Embase, Cinahl, PsychInfo and Cochrane) were systematically searched for randomized controlled trials or cohort studies comparing screening and no screening, or comparing different types of screening for Down's syndrome. The search was limited to studies published between September 2001 and April 2013. In all, 316 studies were identified through search of databases and 40 were included for full-text assessment. Two observers independently screened the articles and seven studies satisfied the inclusion criteria. They were subsequently assessed for risk of bias and level of evidence. MAIN OUTCOME MEASURES: Quantitative measurements of maternal anxiety or worry.
RESULTS: Two studies compared anxiety in pregnant women who accepted or declined screening and showed no difference between groups. All studies described a decrease in anxiety following a screen-negative result. Four studies reported that women's anxiety levels increased significantly upon receiving a screen-positive result. However, after a normal diagnostic result, anxiety levels declined to the same level as for screen-negative women.
CONCLUSION: Studies using quantitative, validated measures to estimate anxiety showed no association between screening and residual anxiety.
© 2014 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Keywords:  Pregnancy; antenatal care and diagnosis; anxiety; down's syndrome; screening

Mesh:

Year:  2014        PMID: 25146713     DOI: 10.1111/aogs.12482

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  18 in total

Review 1.  First trimester screening for pre-eclampsia.

Authors:  Stefan C Kane
Journal:  Obstet Med       Date:  2016-05-14

2.  Men's Knowledge About Maternal Serum Screening for Down Syndrome and their Attitude Towards Amniocentesis.

Authors:  Bojana Brajenović-Milić; Tamara Martinac Dorčić
Journal:  J Genet Couns       Date:  2016-06-14       Impact factor: 2.537

3.  External Quality Assessment of Maternal Serum Levels of Alpha-Fetoprotein, Free Beta-Human Chorionic Gonadotropin, and Unconjugated Estriol in Detecting Down Syndrome and Neural Tube Defects in the Second Trimester of 87 Maternal Serum Samples, Based on 105-139 Days.

Authors:  Yiming Chen; Yijie Chen; Yezhen Shi; Wenwen Ning; Xiaoying Wang; Liyao Li; Huimin Zhang
Journal:  Med Sci Monit       Date:  2022-04-13

4.  Coping with worry while waiting for diagnostic results: a qualitative study of the experiences of pregnant couples following a high-risk prenatal screening result.

Authors:  Stina Lou; Camilla P Nielsen; Lone Hvidman; Olav B Petersen; Mette B Risør
Journal:  BMC Pregnancy Childbirth       Date:  2016-10-21       Impact factor: 3.007

5.  What factors influence health professionals to use decision aids for Down syndrome prenatal screening?

Authors:  Johanie Lépine; Maria Esther Leiva Portocarrero; Agathe Delanoë; Hubert Robitaille; Isabelle Lévesque; François Rousseau; Brenda J Wilson; Anik M C Giguère; France Légaré
Journal:  BMC Pregnancy Childbirth       Date:  2016-09-05       Impact factor: 3.007

6.  Women's Experience with Non-Invasive Prenatal Testing and Emotional Well-being and Satisfaction after Test-Results.

Authors:  Rachèl V van Schendel; G C M Lieve Page-Christiaens; Lean Beulen; Caterina M Bilardo; Marjon A de Boer; Audrey B C Coumans; Brigitte H W Faas; Irene M van Langen; Klaske D Lichtenbelt; Merel C van Maarle; Merryn V E Macville; Dick Oepkes; Eva Pajkrt; Lidewij Henneman
Journal:  J Genet Couns       Date:  2017-06-30       Impact factor: 2.537

7.  Pregnant women's views on how to promote the use of a decision aid for Down syndrome prenatal screening: a theory-informed qualitative study.

Authors:  Titilayo Tatiana Agbadjé; Matthew Menear; Michèle Dugas; Marie-Pierre Gagnon; Samira Abbasgholizadeh Rahimi; Hubert Robitaille; Anik M C Giguère; François Rousseau; Brenda J Wilson; France Légaré
Journal:  BMC Health Serv Res       Date:  2018-06-08       Impact factor: 2.655

8.  Psychosocial Factors of Health Professionals' Intention to Use a Decision Aid for Down Syndrome Screening: Cross-Sectional Quantitative Study.

Authors:  Samira Abbasgholizadeh Rahimi; Johanie Lépine; Jordie Croteau; Hubert Robitaille; Anik Mc Giguere; Brenda J Wilson; François Rousseau; Isabelle Lévesque; France Légaré
Journal:  J Med Internet Res       Date:  2018-04-25       Impact factor: 5.428

9.  Offering non-invasive prenatal testing as part of routine clinical service. Can high levels of informed choice be maintained?

Authors:  Celine Lewis; Melissa Hill; Lyn S Chitty
Journal:  Prenat Diagn       Date:  2017-10-17       Impact factor: 3.050

10.  Facilitating autonomous, confident and satisfying choices: a mixed-method study of women's choice-making in prenatal screening for common aneuploidies.

Authors:  An Chen; Henni Tenhunen; Paulus Torkki; Antti Peltokorpi; Seppo Heinonen; Paul Lillrank; Vedran Stefanovic
Journal:  BMC Pregnancy Childbirth       Date:  2018-05-02       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.